Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Novacare (NOV) breaking out... -- Ignore unavailable to you. Want to Upgrade?

To: Double Dipper who wrote (196)	1/28/1998 11:53:00 AM
From: Todd D. Wiener	Read Replies (3) \| Respond to of 420

Kevin- NCES should be releasing results any day now. Judging by NOV's reporting of the employee services business, NCES should beat estimates of .04. NCES' revenues and gross profits were much stronger in Q2 than the analysts anticipated. Estimates for NCES' profits are about 10% lower than NOV's reported number. I would suggest buying NCES now, before the "Street" catches on. We may even see NCES reiterated as a STRONG BUY before earnings are released. BUY now, believe me later. Todd